SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-024034
Filing Date
2021-05-05
Accepted
2021-05-05 16:06:12
Documents
14
Period of Report
2021-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tptx-8k_20210429.htm   iXBRL 8-K 42879
2 EX-99.1 tptx-ex991_8.htm EX-99.1 212268
3 GRAPHIC gmz5dn4dz2ut000001.jpg GRAPHIC 13648
  Complete submission text file 0001564590-21-024034.txt   422292

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tptx-20210429.xsd EX-101.SCH 5800
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tptx-20210429_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tptx-20210429_pre.xml EX-101.PRE 11648
7 EXTRACTED XBRL INSTANCE DOCUMENT tptx-8k_20210429_htm.xml XML 3576
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38871 | Film No.: 21893221
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences